Batten Disease Clinical Trials

7 recruiting

Batten Disease Trials at a Glance

7 actively recruiting trials for batten disease are listed on ClinicalTrialsFinder across 6 cities in 2 countries. The largest study group is Phase 1 with 1 trial, with the heaviest enrollment activity in Bethesda, Columbia, and Durham. Lead sponsors running batten disease studies include Foundation Fighting Blindness, Joanne Kurtzberg, MD, and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Browse batten disease trials by phase

Treatments under study

About Batten Disease Clinical Trials

Looking for clinical trials for Batten Disease? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Batten Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Batten Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Investigations of Juvenile Neuronal Ceroid Lipofuscinosis

Batten DiseaseJuvenile Neuronal Ceroid Lipofuscinosis (CLN3)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)300 enrolled1 locationNCT03307304
Recruiting

Longitudinal Study of Neurodegenerative Disorders

Gaucher DiseaseBatten DiseaseLeukodystrophy+24 more
University of Pittsburgh1,500 enrolled1 locationNCT03333200
Recruiting

Clinical and Neuropsychological Investigations in Batten Disease

Batten DiseaseNeuronal Ceroid LipofuscinosisNeuronal Ceroid Lipofuscinosis CLN1+7 more
University of Rochester500 enrolled1 locationNCT01873924
Recruiting
Phase 1

UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Batten DiseaseAdrenoleukodystrophyPelizaeus-Merzbacher Disease+9 more
Joanne Kurtzberg, MD40 enrolled1 locationNCT02254863
Recruiting

Inherited Retinal Degenerative Disease Registry

Retinitis PigmentosaBatten DiseaseLeber Congenital Amaurosis+25 more
Foundation Fighting Blindness20,000 enrolled1 locationNCT02435940
Recruiting

NYSCF Scientific Discovery Biobank

Ovarian CancerCervical CancerDiabetes Mellitus+26 more
New York Stem Cell Foundation Research Institute10,000 enrolled1 locationNCT06203106
Recruiting

Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database

Batten DiseaseNeuronal Ceroid LipofuscinosisCLN1 Disease+12 more
Universitätsklinikum Hamburg-Eppendorf500 enrolled1 locationNCT04613089